Researchers have discovered a genetic variant that appears to protect some people from developing CHIP (clonal haematopoiesis of indeterminate potential), a condition characterised by abnormal proliferation of certain blood cells. CHIP can lead to the development of certain blood cancers and other haematological diseases. The genetic variant acts as a protective factor that reduces the risk of developing this dangerous condition. The discovery of this variant represents an important advance in our understanding of the genetic mechanisms that protect the human body from blood cancers. This discovered protection could contribute to the development of new therapeutic approaches for the treatment and prevention of haematological malignancies in the future. The research highlights that some people have innate genetic advantages that naturally protect them from certain diseases.